Oxford Global Conferences Ltd are proud to present the 4th Annual Cell Culture & Bioprocessing Congress, taking place on the 9th and 10th November 2015 at the Royal College of Surgeons in London, United Kingdom. This event is co-located with the 2nd Annual Stem Cell Congress 2015 and our new Cell and Gene Therapy Congress.
About the Congress
This Congress is an executive platform for over 170 experts to network, exchange ideas, and discuss the latest innovations in the field. Delegates come from a variety of areas, including cell line development, cell line engineering, up and downstream operations, biotechnology, process development, biologics production and more.
The value of the cell culture industry is experiencing extraordinary growth, with a projected value of around $24 billion by 2018. Our Congress will bring together leading minds in the field to discuss ways to address industry challenges and growth. Supporting this exchange will be key solution providers; in 2014 these included Merck Millipore, Eppendorf, Solentim, ProteoNic and Irvine Scientific. Providing a comprehensive round up of the latest in cell culture and biological processing, the conference will cover subjects spanning from raw materials quality control and novel cell line development technologies, to advances in process development and strategies to deal with moving to clinical trial and manufacture.
On Day One, the conference will address stem cell development, gene-editing, cell genome NGS sequencing and CRISPR technology. Our expert speakers will discuss technologies for precise genome editing as well as the potential uses gene editing could have in future, how to ensure quality of raw materials in stem cell culture, and 3D cell culture technologies. Key issues to be covered in our Process Development stream include novel single use technologies, analytics development and the processing of Bispecific antibodies.
Day two of the event will see our leading industry and academic speakers present subjects such as the optimisation of cell lines, contamination issues in manufacture, efficient technology transfer, strategies in the use of Quality by Design, and the future of continuous processing. Other key topics that delegates will have the opportunity to hear about include first hand experiences from speakers of biosimilar cell line development, and innovation in the early development of bispecific antibodies. Our cell line development stream will have a focus on innovation in the use of both mammalian and bacterial expression systems.
In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 40 speakers will present a full conference programme covering the topics outlined below.
Day 1 Stream 1 – Cell Line Development: Stem Cells, Genome-Editing, CRISPR & NGS
- Genome editing & CRISPR
- Cell genome NGS sequencing
- The latest in stem cell culture
- Managing quality of raw materials
- Stem cell development for disease modelling
- 3D cell culture technologies
- The future of genome editing for therapeutic use
Day 1 Stream 2 – Process Development
- Efficient upstream processing
- Fed-batch & perfusion processes
- Process development for bispecific antibodies
- Analytics: development & technologies
- High throughput technologies in bioprocessing
- Purification & product quality
- Single use technologies inc. disposable bioreactors
- Innovative approaches to scale-up
Day 2 Stream 1 – Cell Line Development: Mammalian & Bacterial Expression Systems
- Efficient cell line engineering approaches
- Novel bacterial expression systems
- Optimising bispecific cell line development
- Innovative cell line tools and technologies
- Biosimilar cell line development case studies
- Stable CHO platform development
- Innovative media options inc. serum-free
- Difficult-to-express proteins
Day 2 Stream 2 – Biological Production
- Bio-manufacturing case studies
- Technology transfer to production level
- Approaches to commercial cell banking
- Contamination prevention in manufacture
- Outsourcing strategies for biologics production
- The future of continuous processing
- Perspectives on tackling PAT & QbD challenges
Submit a poster
For attendees interested in submitting a poster, there are opportunities now available. Your poster presentation will be located in the exhibition room for two days alongside other posters from senior scientists working in industry and academia.
How to submit your abstract
We will require:
- Poster title, Abstract (200 words or less)
- Principal author, Organisation
- Mailing address, Email, Telephone, Fax
- Additional authors
In order to secure your board space a fee of £250 plus VAT will be required. The poster should be presented as A0 (841mm x 1189mm) portrait size.To take advantage of this opportunity you need to be registered as a paid delegate over the 2 days. We have limited spaces available, so please register soon!